CLINICAL_TRIALS
trial_result
· 2013-08-12
Clinical Trial Update: Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1 [Phase 4]
Summary
Phase 4 trial evaluating raltegravir in HIV-1 infected CD4 cells during acute/early HIV-1 was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Human Immunodeficiency Virus | Phase 4 | Status: TERMINATED